Covid-19 Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

List of Figures, Tables and Charts Available in Covid-19 Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

List of Tables
Table 1. Covid-19 Vaccine Market Trends
Table 2. Covid-19 Vaccine Market Drivers & Opportunity
Table 3. Covid-19 Vaccine Market Challenges
Table 4. Covid-19 Vaccine Market Restraints
Table 5. Global Covid-19 Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Covid-19 Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Covid-19 Vaccine Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Covid-19 Vaccine Product Type
Table 9. Key Companies Time to Begin Mass Production of Covid-19 Vaccine
Table 10. Global Covid-19 Vaccine Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Vaccine as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Covid-19 Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Covid-19 Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Covid-19 Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Covid-19 Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Covid-19 Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Covid-19 Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Covid-19 Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Covid-19 Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Covid-19 Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Covid-19 Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Covid-19 Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Covid-19 Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Covid-19 Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Covid-19 Vaccine Sales Value by Region (2019-2024) & (%)
Table 27. Global Covid-19 Vaccine Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Covid-19 Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Covid-19 Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Covid-19 Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 31. Moderna Basic Information List
Table 32. Moderna Description and Business Overview
Table 33. Moderna Covid-19 Vaccine Products, Services and Solutions
Table 34. Revenue (US$ Million) in Covid-19 Vaccine Business of Moderna (2019-2024)
Table 35. Moderna Recent Developments
Table 36. CanSino Biologicals Basic Information List
Table 37. CanSino Biologicals Description and Business Overview
Table 38. CanSino Biologicals Covid-19 Vaccine Products, Services and Solutions
Table 39. Revenue (US$ Million) in Covid-19 Vaccine Business of CanSino Biologicals (2019-2024)
Table 40. CanSino Biologicals Recent Developments
Table 41. Inovio Pharmaceuticals Basic Information List
Table 42. Inovio Pharmaceuticals Description and Business Overview
Table 43. Inovio Pharmaceuticals Covid-19 Vaccine Products, Services and Solutions
Table 44. Revenue (US$ Million) in Covid-19 Vaccine Business of Inovio Pharmaceuticals (2019-2024)
Table 45. Inovio Pharmaceuticals Recent Developments
Table 46. Shenzhen Geno-Immune Medical Institute Basic Information List
Table 47. Shenzhen Geno-Immune Medical Institute Description and Business Overview
Table 48. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Products, Services and Solutions
Table 49. Revenue (US$ Million) in Covid-19 Vaccine Business of Shenzhen Geno-Immune Medical Institute (2019-2024)
Table 50. Shenzhen Geno-Immune Medical Institute Recent Developments
Table 51. GlaxoSmithKine Basic Information List
Table 52. GlaxoSmithKine Description and Business Overview
Table 53. GlaxoSmithKine Covid-19 Vaccine Products, Services and Solutions
Table 54. Revenue (US$ Million) in Covid-19 Vaccine Business of GlaxoSmithKine (2019-2024)
Table 55. GlaxoSmithKine Recent Developments
Table 56. Pfizer Basic Information List
Table 57. Pfizer Description and Business Overview
Table 58. Pfizer Covid-19 Vaccine Products, Services and Solutions
Table 59. Revenue (US$ Million) in Covid-19 Vaccine Business of Pfizer (2019-2024)
Table 60. Pfizer Recent Developments
Table 61. Johnson＆Johnson Basic Information List
Table 62. Johnson＆Johnson Description and Business Overview
Table 63. Johnson＆Johnson Covid-19 Vaccine Products, Services and Solutions
Table 64. Revenue (US$ Million) in Covid-19 Vaccine Business of Johnson＆Johnson (2019-2024)
Table 65. Johnson＆Johnson Recent Developments
Table 66. Heat Biologics Basic Information List
Table 67. Heat Biologics Description and Business Overview
Table 68. Heat Biologics Covid-19 Vaccine Products, Services and Solutions
Table 69. Revenue (US$ Million) in Covid-19 Vaccine Business of Heat Biologics (2019-2024)
Table 70. Heat Biologics Recent Developments
Table 71. Sanofi Basic Information List
Table 72. Sanofi Description and Business Overview
Table 73. Sanofi Covid-19 Vaccine Products, Services and Solutions
Table 74. Revenue (US$ Million) in Covid-19 Vaccine Business of Sanofi (2019-2024)
Table 75. Sanofi Recent Developments
Table 76. Key Raw Materials Lists
Table 77. Raw Materials Key Suppliers Lists
Table 78. Covid-19 Vaccine Downstream Customers
Table 79. Covid-19 Vaccine Distributors List
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Covid-19 Vaccine Product Picture
Figure 2. Global Covid-19 Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Covid-19 Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Covid-19 Vaccine Report Years Considered
Figure 5. Global Covid-19 Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Covid-19 Vaccine Revenue in 2023
Figure 7. Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. DNA Picture
Figure 9. Non-replicating Viral Vector Picture
Figure 10. Protein Subunit Picture
Figure 11. RNA Picture
Figure 12. Others Picture
Figure 13. Global Covid-19 Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Covid-19 Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Adults
Figure 16. Product Picture of Children
Figure 17. Global Covid-19 Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Covid-19 Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Covid-19 Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Covid-19 Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Covid-19 Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Covid-19 Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Covid-19 Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Covid-19 Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Covid-19 Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Covid-19 Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Covid-19 Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Covid-19 Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Covid-19 Vaccine Sales Value (%), (2019-2030)
Figure 30. United States Covid-19 Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Covid-19 Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Covid-19 Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Covid-19 Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Covid-19 Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Covid-19 Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 36. China Covid-19 Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Covid-19 Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 38. China Covid-19 Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Covid-19 Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Covid-19 Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Covid-19 Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Covid-19 Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Covid-19 Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Covid-19 Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Covid-19 Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Covid-19 Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Covid-19 Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 48. India Covid-19 Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Covid-19 Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 50. India Covid-19 Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 51. Covid-19 Vaccine Industrial Chain
Figure 52. Covid-19 Vaccine Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation